Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2004 3
2005 1
2006 2
2007 4
2008 8
2009 8
2010 8
2011 3
2012 12
2013 7
2014 13
2015 13
2016 12
2017 12
2018 14
2019 6
2020 10
2021 35
2022 19
2023 18
2024 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

202 results

Results by year

Filters applied: . Clear all
Page 1
A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease.
Cheifetz AS, Abreu MT, Afif W, Cross RK, Dubinsky MC, Loftus EV Jr, Osterman MT, Saroufim A, Siegel CA, Yarur AJ, Melmed GY, Papamichael K. Cheifetz AS, et al. Among authors: melmed gy. Am J Gastroenterol. 2021 Oct 1;116(10):2014-2025. doi: 10.14309/ajg.0000000000001396. Am J Gastroenterol. 2021. PMID: 34388143 Free PMC article. Review.
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials.
Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L, Colombel JF, Parkes G, Peyrin-Biroulet L, D'Haens G, Hisamatsu T, Siegmund B, Wu K, Boland BS, Melmed GY, Armuzzi A, Levine P, Kalabic J, Chen S, Cheng L, Shu L, Duan WR, Pivorunas V, Sanchez Gonzalez Y, D'Cunha R, Neimark E, Wallace K, Atreya R, Ferrante M, Loftus EV Jr; INSPIRE and COMMAND Study Group. Louis E, et al. Among authors: melmed gy. JAMA. 2024 Sep 17;332(11):881-897. doi: 10.1001/jama.2024.12414. JAMA. 2024. PMID: 39037800 Clinical Trial.
Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.
Papamichael K, Cheifetz AS, Melmed GY, Irving PM, Vande Casteele N, Kozuch PL, Raffals LE, Baidoo L, Bressler B, Devlin SM, Jones J, Kaplan GG, Sparrow MP, Velayos FS, Ullman T, Siegel CA. Papamichael K, et al. Among authors: melmed gy. Clin Gastroenterol Hepatol. 2019 Aug;17(9):1655-1668.e3. doi: 10.1016/j.cgh.2019.03.037. Epub 2019 Mar 27. Clin Gastroenterol Hepatol. 2019. PMID: 30928454 Free PMC article.
Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis.
Panaccione R, Collins EB, Melmed GY, Vermeire S, Danese S, Higgins PDR, Kwon CS, Zhou W, Ilo D, Sharma D, Sanchez Gonzalez Y, Wang ST. Panaccione R, et al. Among authors: melmed gy. Crohns Colitis 360. 2023 Mar 1;5(2):otad009. doi: 10.1093/crocol/otad009. eCollection 2023 Apr. Crohns Colitis 360. 2023. PMID: 36998249 Free PMC article.
Reply.
Melmed GY, Cohen ER. Melmed GY, et al. Clin Gastroenterol Hepatol. 2018 Nov;16(11):1840. doi: 10.1016/j.cgh.2018.07.005. Clin Gastroenterol Hepatol. 2018. PMID: 30343867 No abstract available.
Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study.
Yarur AJ, Bruss A, Moosreiner A, Beniwal-Patel P, Nunez L, Berens B, Colombel JF, Targan SR, Fox C, Melmed GY, Abreu MT, Deepak P. Yarur AJ, et al. Among authors: melmed gy. Gastroenterology. 2023 Oct;165(4):963-975.e5. doi: 10.1053/j.gastro.2023.06.036. Epub 2023 Jul 25. Gastroenterology. 2023. PMID: 37499955 Free PMC article.
Imaging in Inflammatory Bowel Disease.
Kumar R, Melmed GY, Gu P. Kumar R, et al. Among authors: melmed gy. Rheum Dis Clin North Am. 2024 Nov;50(4):721-733. doi: 10.1016/j.rdc.2024.07.009. Epub 2024 Aug 26. Rheum Dis Clin North Am. 2024. PMID: 39415376 Review.
Certolizumab pegol.
Melmed GY, Targan SR, Yasothan U, Hanicq D, Kirkpatrick P. Melmed GY, et al. Nat Rev Drug Discov. 2008 Aug;7(8):641-2. doi: 10.1038/nrd2654. Nat Rev Drug Discov. 2008. PMID: 18670430
Quality indicators in inflammatory bowel disease.
Berry SK, Melmed GY. Berry SK, et al. Among authors: melmed gy. Intest Res. 2018 Jan;16(1):43-47. doi: 10.5217/ir.2018.16.1.43. Epub 2018 Jan 18. Intest Res. 2018. PMID: 29422796 Free PMC article. Review.
202 results